Scinai Immunotherapeutics Ltd. Quarterly Assets in USD from Q4 2021 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Scinai Immunotherapeutics Ltd. quarterly Assets history and growth rate from Q4 2021 to Q2 2024.
Scinai Immunotherapeutics Ltd. Assets for the quarter ending June 30, 2024 was $14.9M, a 25.4% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$14.9M	-$5.05M	-25.4%	Jun 30, 2024	6-K	2024-09-09
Q4 2023	$17.5M	-$9.6M	-35.4%	Dec 31, 2023	6-K	2024-09-09
Q2 2023	$19.9M	-$4.55M	-18.6%	Jun 30, 2023	6-K/A	2023-08-18
Q1 2023	$23.3M			Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$27.1M	-$4.97M	-15.5%	Dec 31, 2022	20-F	2024-05-15
Q4 2021	$32M	+$14.3M	+81%	Dec 31, 2021	10-K	2023-04-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.